CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 1 filers reported holding CONATUS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $0 | – | 0 | – | 0.00% | – |
Q1 2021 | $0 | – | 0 | – | 0.00% | – |
Q4 2020 | $0 | – | 0 | – | 0.00% | – |
Q3 2020 | $0 | – | 0 | – | 0.00% | – |
Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Q1 2020 | $0 | – | 0 | – | 0.00% | – |
Q4 2019 | $0 | – | 0 | – | 0.00% | – |
Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q4 2018 | $11,000 | -54.2% | 8,255 | +50.1% | 0.00% | 0.0% |
Q2 2018 | $24,000 | +50.0% | 5,500 | +59.2% | 0.00% | 0.0% |
Q1 2018 | $16,000 | 0.0% | 3,455 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $16,000 | -48.4% | 3,455 | -38.0% | 0.00% | 0.0% |
Q3 2017 | $31,000 | +93.8% | 5,575 | +106.5% | 0.00% | 0.0% |
Q2 2017 | $16,000 | +300.0% | 2,700 | +285.7% | 0.00% | – |
Q1 2017 | $4,000 | -50.0% | 700 | -56.2% | 0.00% | – |
Q4 2016 | $8,000 | +700.0% | 1,600 | +128.6% | 0.00% | – |
Q3 2016 | $1,000 | 0.0% | 700 | 0.0% | 0.00% | – |
Q2 2016 | $1,000 | -50.0% | 700 | 0.0% | 0.00% | – |
Q4 2015 | $2,000 | – | 700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kalos Management, Inc. | 47,500 | $12,000 | 0.01% |
Virtu Financial LLC | 94,842 | $25,000 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 467,425 | $121,000 | 0.00% |
REILLY FINANCIAL ADVISORS, LLC | 22,011 | $6,000 | 0.00% |
A.R.T. Advisors, LLC | 60,430 | $16,000 | 0.00% |
GOLDMAN SACHS GROUP INC | 25,350 | $7,000 | 0.00% |
MORGAN STANLEY | 1,019 | $0 | 0.00% |
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 24,900 | $6,000 | 0.00% |
WOLVERINE TRADING, LLC | 30,900 | $8,000 | 0.00% |
WOLVERINE TRADING, LLC | 26,779 | $7,000 | 0.00% |